{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:48:05Z","timestamp":1785322085076,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ONWAR Imaging"},{"name":"AMC Graduate School"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00259-017-3664-x","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T02:30:54Z","timestamp":1489717854000},"page":"1375-1382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The relationship between the dopaminergic system and depressive symptoms in cervical dystonia"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-109X","authenticated-orcid":false,"given":"E.","family":"Zoons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A. J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. E. M.","family":"Dreissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Speelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"issue":"7","key":"3664_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863\u201373.","journal-title":"Mov Disord"},{"issue":"8","key":"3664_CR2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMra055549","volume":"355","author":"D Tarsy","year":"2006","unstructured":"Tarsy D, Simon DK. Dystonia. N Engl J Med. 2006;355(8):818\u201329.","journal-title":"N Engl J Med"},{"issue":"6","key":"3664_CR3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.parkreldis.2013.02.017","volume":"19","author":"I Rubio-Agusti","year":"2013","unstructured":"Rubio-Agusti I et al. Tremulous cervical dystonia is likely to be familial: clinical characteristics of a large cohort. Parkinsonism Relat Disord. 2013;19(6):634\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"3664_CR4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mds.26231","volume":"30","author":"AG Shaikh","year":"2015","unstructured":"Shaikh AG, Zee DS, Jinnah HA. Oscillatory head movements in cervical dystonia: dystonia, tremor, or both? Mov Disord. 2015;30(6):834\u201342.","journal-title":"Mov Disord"},{"issue":"7","key":"3664_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.NMD.0000081667.02656.21","volume":"191","author":"H Gundel","year":"2003","unstructured":"Gundel H et al. High psychiatric comorbidity in spasmodic torticollis: a controlled study. J Nerv Ment Dis. 2003;191(7):465\u201373.","journal-title":"J Nerv Ment Dis"},{"issue":"7","key":"3664_CR6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/01.wnl.0000253188.76092.06","volume":"68","author":"CW Hess","year":"2007","unstructured":"Hess CW et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology. 2007;68(7):522\u20134.","journal-title":"Neurology"},{"key":"3664_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.06.004","volume":"30","author":"M Smit","year":"2016","unstructured":"Smit M et al. Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: results of a controlled study. Parkinsonism Relat Disord. 2016;30:7\u201312.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"3664_CR8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","volume":"39","author":"D Giuda Di","year":"2012","unstructured":"Di Giuda D et al. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2012;39(12):1937\u201348.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"3664_CR9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00415-014-7244-8","volume":"261","author":"A Lehn","year":"2014","unstructured":"Lehn A, Mellick G, Boyle R. Psychiatric disorders in idiopathic-isolated focal dystonia. J Neurol. 2014;261(4):668\u201374.","journal-title":"J Neurol"},{"issue":"1","key":"3664_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jb\/mvj138","volume":"140","author":"F Yokoi","year":"2006","unstructured":"Yokoi F et al. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem. 2006;140(1):141\u20136.","journal-title":"J Biochem"},{"issue":"1","key":"3664_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2012.05.009","volume":"48","author":"CH Song","year":"2012","unstructured":"Song CH et al. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis. 2012;48(1):66\u201378.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3664_CR12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.parkreldis.2006.09.003","volume":"13","author":"HJ Berger","year":"2007","unstructured":"Berger HJ et al. Writer\u2019s cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training. Parkinsonism Relat Disord. 2007;13(3):170\u20133.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"3664_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00259-008-0924-9","volume":"36","author":"RJ Beukers","year":"2009","unstructured":"Beukers RJ et al. Reduced striatal D2 receptor binding in myoclonus-dystonia. Eur J Nucl Med Mol Imaging. 2009;36(2):269\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"3664_CR14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.62.6.672-a","volume":"62","author":"CA Horstink","year":"1997","unstructured":"Horstink CA et al. Low striatal D2 receptor binding as assessed by [123I]IBZM SPECT in patients with writer\u2019s cramp. J Neurol Neurosurg Psychiatry. 1997;62(6):672\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3664_CR15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mds.870130219","volume":"13","author":"M Naumann","year":"1998","unstructured":"Naumann M et al. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Mov Disord. 1998;13(2):319\u201323.","journal-title":"Mov Disord"},{"issue":"7","key":"3664_CR16","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/npp.2012.17","volume":"37","author":"MJ Ferris","year":"2012","unstructured":"Ferris MJ et al. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology. 2012;37(7):1708\u201316.","journal-title":"Neuropsychopharmacology"},{"issue":"27","key":"3664_CR17","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1073\/pnas.1402134111","volume":"111","author":"KM Lohr","year":"2014","unstructured":"Lohr KM et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proc Natl Acad Sci U S A. 2014;111(27):9977\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3664_CR18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","volume":"13","author":"A Anand","year":"2011","unstructured":"Anand A et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13(4):406\u201313.","journal-title":"Bipolar Disord"},{"issue":"18","key":"3664_CR19","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1097\/00001756-200112210-00052","volume":"12","author":"JH Meyer","year":"2001","unstructured":"Meyer JH et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport. 2001;12(18):4121\u20135.","journal-title":"Neuroreport"},{"issue":"7","key":"3664_CR20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2014;29(7):904\u201311.","journal-title":"Mov Disord"},{"issue":"8501","key":"3664_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","volume":"2","author":"JK Tsui","year":"1986","unstructured":"Tsui JK et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986;2(8501):245\u20137.","journal-title":"Lancet"},{"issue":"2","key":"3664_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","volume":"35","author":"J Booij","year":"2008","unstructured":"Booij J, Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging. 2008;35(2):424\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3664_CR23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","volume":"12","author":"D Tarsy","year":"1997","unstructured":"Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord. 1997;12(1):100\u20132.","journal-title":"Mov Disord"},{"key":"3664_CR24","first-page":"361","volume":"89","author":"SJ Frucht","year":"2002","unstructured":"Frucht SJ et al. The unified myoclonus rating scale. Adv Neurol. 2002;89:361\u201376.","journal-title":"Adv Neurol"},{"issue":"11","key":"3664_CR25","first-page":"1879","volume":"39","author":"J Booij","year":"1998","unstructured":"Booij J et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease. J Nucl Med. 1998;39(11):1879\u201384.","journal-title":"J Nucl Med"},{"issue":"Suppl 3","key":"3664_CR26","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1016\/S1353-8020(08)70042-7","volume":"13","author":"J Booij","year":"2007","unstructured":"Booij J, Knol RJ. SPECT imaging of the dopaminergic system in (premotor) Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13 Suppl 3:S425\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"3664_CR27","first-page":"674","volume":"24","author":"J Booij","year":"1997","unstructured":"Booij J et al. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography. Eur J Nucl Med. 1997;24(6):674\u20137.","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"3664_CR28","first-page":"1182","volume":"36","author":"M Laruelle","year":"1995","unstructured":"Laruelle M et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med. 1995;36(7):1182\u201390.","journal-title":"J Nucl Med"},{"issue":"7","key":"3664_CR29","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00259-008-0739-8","volume":"35","author":"E Boot","year":"2008","unstructured":"Boot E et al. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. Eur J Nucl Med Mol Imaging. 2008;35(7):1350\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3664_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;62(2):133\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"3664_CR31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2967\/jnumed.111.102277","volume":"53","author":"KE Koopman","year":"2012","unstructured":"Koopman KE et al. Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects. J Nucl Med. 2012;53(7):1087\u201390.","journal-title":"J Nucl Med"},{"issue":"8","key":"3664_CR32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2013.06.021","volume":"75","author":"M Figee","year":"2014","unstructured":"Figee M et al. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder. Biol Psychiatry. 2014;75(8):647\u201352.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"3664_CR33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"3664_CR34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/MNM.0b013e328364aa2e","volume":"34","author":"S Jakobson Mo","year":"2013","unstructured":"Jakobson Mo S et al. (1)(2)(3)I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools. Nucl Med Commun. 2013;34(10):978\u201389.","journal-title":"Nucl Med Commun"},{"issue":"7","key":"3664_CR35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","volume":"27","author":"J Lavalaye","year":"2000","unstructured":"Lavalaye J et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med. 2000;27(7):867\u20139.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"3664_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00259-012-2276-8","volume":"40","author":"A Varrone","year":"2013","unstructured":"Varrone A et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40(2):213\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"3664_CR37","first-page":"1921","volume":"35","author":"J Hierholzer","year":"1994","unstructured":"Hierholzer J et al. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis. J Nucl Med. 1994;35(12):1921\u20137.","journal-title":"J Nucl Med"},{"issue":"12","key":"3664_CR38","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/jnnp.2007.121699","volume":"78","author":"H Gundel","year":"2007","unstructured":"Gundel H et al. Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study. J Neurol Neurosurg Psychiatry. 2007;78(12):1398\u2013400.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"3664_CR39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2008.170191","volume":"80","author":"R Lencer","year":"2009","unstructured":"Lencer R et al. Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry. 2009;80(10):1176\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3664_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000368117","volume":"70","author":"G Camardese","year":"2014","unstructured":"Camardese G et al. Changes of dopamine transporter availability in depressed patients with and without anhedonia: a 123I-N-omega-fluoropropyl-carbomethoxy-3beta- (4-Iodophenyl)tropane SPECT study. Neuropsychobiology. 2014;70(4):235\u201343.","journal-title":"Neuropsychobiology"},{"key":"3664_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.06.001","volume":"52","author":"JB Savitz","year":"2013","unstructured":"Savitz JB, Drevets WC. Neuroreceptor imaging in depression. Neurobiol Dis. 2013;52:49\u201365.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3664_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/YIC.0b013e32835ebcd7","volume":"28","author":"CK Wu","year":"2013","unstructured":"Wu CK et al. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression. Int Clin Psychopharmacol. 2013;28(3):141\u20134.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"3664_CR43","first-page":"5","volume":"46","author":"T Furmark","year":"2009","unstructured":"Furmark T. Neurobiological aspects of social anxiety disorder. Isr J Psychiatry Relat Sci. 2009;46(1):5\u201312.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"5","key":"3664_CR44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/da.20543","volume":"26","author":"FR Schneier","year":"2009","unstructured":"Schneier FR et al. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder. Depress Anxiety. 2009;26(5):411\u20138.","journal-title":"Depress Anxiety"},{"key":"3664_CR45","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/tp.2012.40","volume":"2","author":"S Cervenka","year":"2012","unstructured":"Cervenka S et al. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Transl Psychiatry. 2012;2:e120.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"3664_CR46","doi-asserted-by":"crossref","first-page":"e113612","DOI":"10.1371\/journal.pone.0113612","volume":"9","author":"BP Kwaasteniet de","year":"2014","unstructured":"de Kwaasteniet BP et al. Striatal dopamine D2\/3 receptor availability in treatment resistant depression. PLoS One. 2014;9(11):e113612.","journal-title":"PLoS One"},{"issue":"4 Pt 1","key":"3664_CR47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/nimg.1997.0267","volume":"5","author":"R Larisch","year":"1997","unstructured":"Larisch R et al. In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression. Neuroimage. 1997;5(4 Pt 1):251\u201360.","journal-title":"Neuroimage"},{"issue":"3","key":"3664_CR48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-008-0979-7","volume":"36","author":"S Hesse","year":"2009","unstructured":"Hesse S et al. Monoamine transporter availability in Parkinson\u2019s disease patients with or without depression. Eur J Nucl Med Mol Imaging. 2009;36(3):428\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3664_CR49","doi-asserted-by":"crossref","first-page":"e88121","DOI":"10.1371\/journal.pone.0088121","volume":"9","author":"KJ Black","year":"2014","unstructured":"Black KJ et al. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. PLoS One. 2014;9(2):e88121.","journal-title":"PLoS One"},{"issue":"1","key":"3664_CR50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/11590750-000000000-00000","volume":"11","author":"A Pickett","year":"2011","unstructured":"Pickett A. Consistent biochemical data are essential for comparability of botulinum toxin type A products. Drugs R&D. 2011;11(1):97\u20138. author reply 98\u20139.","journal-title":"Drugs R&D"},{"issue":"10","key":"3664_CR51","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.12-10-03773.1992","volume":"12","author":"SL Dewey","year":"1992","unstructured":"Dewey SL et al. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci. 1992;12(10):3773\u201380.","journal-title":"J Neurosci"},{"issue":"2","key":"3664_CR52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pscychresns.2009.04.006","volume":"174","author":"H Vilkman","year":"2009","unstructured":"Vilkman H et al. The effects of lorazepam on extrastriatal dopamine D(2\/3)-receptors-A double-blind randomized placebo-controlled PET study. Psychiatry Res. 2009;174(2):130\u20137.","journal-title":"Psychiatry Res"},{"issue":"2\u20133","key":"3664_CR53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2011.03.011","volume":"118","author":"H Hou","year":"2011","unstructured":"Hou H et al. Decreased striatal dopamine transporters in codeine-containing cough syrup abusers. Drug Alcohol Depend. 2011;118(2\u20133):148\u201351.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3664_CR54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-013-3148-z","volume":"230","author":"Y Liu","year":"2013","unstructured":"Liu Y et al. Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment. Psychopharmacology (Berlin). 2013;230(2):235\u201344.","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1","key":"3664_CR55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00213-011-2454-6","volume":"220","author":"TL Yeh","year":"2012","unstructured":"Yeh TL et al. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Psychopharmacology (Berl). 2012;220(1):55\u201364.","journal-title":"Psychopharmacology (Berl)"},{"issue":"14","key":"3664_CR56","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00213-015-3891-4","volume":"232","author":"ER Zaaijer","year":"2015","unstructured":"Zaaijer ER et al. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. Psychopharmacology (Berl). 2015;232(14):2597\u2013607.","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"3664_CR57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2010.09.014","volume":"35","author":"HY Tsai","year":"2011","unstructured":"Tsai HY et al. Sunshine-exposure variation of human striatal dopamine D(2)\/D(3) receptor availability in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(1):107\u201310.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"3664_CR58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pnpbp.2007.08.018","volume":"32","author":"YK Yang","year":"2008","unstructured":"Yang YK et al. Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):274\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"3664_CR59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2191-219X-3-39","volume":"3","author":"G Thomsen","year":"2013","unstructured":"Thomsen G et al. No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. EJNMMI Res. 2013;3(1):39.","journal-title":"EJNMMI Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3664-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:39:56Z","timestamp":1568914796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3664-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3664"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3664-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}